Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

KCNMA1 inhibits transport. 2 / 2

| 1 1

➶

reach

"Particularly if one considers that sublytic concentrations of SLO or PFO can inhibit or even abolish : (a) phagocytosis by macrophages, (b) mobility and chemotaxis of neutrophils, (c) mitogenesis of l[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

7984032

➶

sparser

"Phagocytosed GAS can increase its survival by the expression of the pore-forming cytolysin SLO which inhibits the transport of GAS to lysosomes and facilitates escape of GAS from lysosomes (Nakagawa et al., xref ; Hakansson et al., xref )."

25325020

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...